# Kymera Therapeutics, Inc.: filings

KYMR · Nasdaq · CIK 1815442 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kymr.md) · [Financials](/companies/kymr/financials.md) · [Filings](/companies/kymr/filings.md) · [Insiders](/companies/kymr/insiders.md)

## Reports and events: 123 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 265, 144 118, 8-K 77, 3 28, SC 13G/A 22, 10-Q 18, SCHEDULE 13G/A 15, SC 13G 10, 424B5 9, CORRESP 8, S-8 7, 10-K 6, DEF 14A 6, DEFA14A 6, SC 13D/A 5, UPLOAD 5, ARS 4, SCHEDULE 13D/A 4, 4/A 3, S-1/A 3, 424B3 2, 424B4 2, DRS 2, EFFECT 2, S-1 2, S-1MEF 2, S-3ASR 2, SC 13D 2, SEC STAFF LETTER 2, 8-A12B 1, CERT 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:10 ET | [8-K](/filings/0001193125-26-436965.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436965 |
| 2026-08-05 | 07:15 ET | [10-Q](/filings/0001193125-26-333849.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333849 |
| 2026-08-05 | 07:10 ET | [8-K](/filings/0001193125-26-333834.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333834 |
| 2026-07-27 | 16:10 ET | [8-K](/filings/0001193125-26-318078.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-318078 |
| 2026-06-26 | 18:43 ET | [SCHEDULE 13D/A](/filings/0000921895-26-001687.md) | Ownership report, active investor, amended | 0000921895-26-001687 |
| 2026-06-25 | 07:10 ET | [8-K](/filings/0001193125-26-281817.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-281817 |
| 2026-06-24 | 16:07 ET | [8-K](/filings/0001193125-26-281051.md) | 5.07 Shareholder vote results | 0001193125-26-281051 |
| 2026-06-08 | 16:05 ET | [8-K](/filings/0001193125-26-261698.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-261698 |
| 2026-04-30 | 07:15 ET | [10-Q](/filings/0001193125-26-193967.md) | Quarterly report, period 2026-03-31 | 0001193125-26-193967 |
| 2026-04-30 | 07:10 ET | [8-K](/filings/0001193125-26-193957.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-193957 |
| 2026-04-29 | 16:05 ET | [DEF 14A](/filings/0001193125-26-191495.md) | Proxy statement, period 2026-06-24 | 0001193125-26-191495 |
| 2026-03-27 | 16:30 ET | [8-K](/filings/0001193125-26-129170.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-129170 |
| 2026-02-26 | 08:22 ET | [8-K](/filings/0001193125-26-073561.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-073561 |
| 2026-02-26 | 07:15 ET | [10-K](/filings/0001193125-26-073395.md) | Annual report, period 2025-12-31 | 0001193125-26-073395 |
| 2026-02-26 | 07:10 ET | [8-K](/filings/0001193125-26-073386.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073386 |
| 2026-01-13 | 07:08 ET | [8-K](/filings/0001193125-26-011104.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-011104 |
| 2025-12-15 | 18:07 ET | [SCHEDULE 13D/A](/filings/0000921895-25-003346.md) | Ownership report, active investor, amended | 0000921895-25-003346 |
| 2025-12-11 | 17:27 ET | [SCHEDULE 13D/A](/filings/0001104659-25-120356.md) | Ownership report, active investor, amended | 0001104659-25-120356 |
| 2025-12-10 | 17:17 ET | [8-K](/filings/0001193125-25-314422.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-314422 |
| 2025-12-08 | 08:45 ET | [8-K](/filings/0001193125-25-310670.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-310670 |
| 2025-12-08 | 07:17 ET | [8-K](/filings/0001193125-25-310572.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310572 |
| 2025-11-04 | 07:15 ET | [10-Q](/filings/0001193125-25-263550.md) | Quarterly report, period 2025-09-30 | 0001193125-25-263550 |
| 2025-11-04 | 07:10 ET | [8-K](/filings/0001193125-25-263540.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-263540 |
| 2025-09-03 | 07:10 ET | [8-K](/filings/0001193125-25-194481.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-194481 |
| 2025-08-11 | 07:15 ET | [10-Q](/filings/0000950170-25-106229.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106229 |
| 2025-08-11 | 07:10 ET | [8-K](/filings/0000950170-25-106227.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106227 |
| 2025-06-30 | 20:26 ET | [SCHEDULE 13D/A](/filings/0001104659-25-064298.md) | Ownership report, active investor, amended | 0001104659-25-064298 |
| 2025-06-27 | 16:55 ET | [8-K](/filings/0001193125-25-151393.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-151393 |
| 2025-06-27 | 16:32 ET | [8-K](/filings/0001193125-25-151345.md) | 5.07 Shareholder vote results | 0001193125-25-151345 |
| 2025-06-25 | 07:12 ET | [8-K](/filings/0001193125-25-146135.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-146135 |
| 2025-06-25 | 07:10 ET | [8-K](/filings/0001193125-25-146134.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-146134 |
| 2025-06-02 | 08:30 ET | [8-K](/filings/0001193125-25-132838.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-132838 |
| 2025-06-02 | 07:05 ET | [8-K](/filings/0001193125-25-132760.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132760 |
| 2025-05-09 | 07:15 ET | [10-Q](/filings/0000950170-25-067498.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067498 |
| 2025-05-09 | 07:05 ET | [8-K](/filings/0001193125-25-116443.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-116443 |
| 2025-04-29 | 16:05 ET | [DEF 14A](/filings/0001193125-25-103767.md) | Proxy statement, period 2025-06-25 | 0001193125-25-103767 |
| 2025-03-03 | 16:30 ET | [8-K](/filings/0001193125-25-044151.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-044151 |
| 2025-02-27 | 07:15 ET | [10-K](/filings/0000950170-25-028355.md) | Annual report, period 2024-12-31 | 0000950170-25-028355 |
| 2025-02-27 | 07:13 ET | [8-K](/filings/0001193125-25-037588.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-037588 |
| 2025-01-14 | 16:02 ET | [8-K](/filings/0001193125-25-006124.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-006124 |
| 2024-10-31 | 07:45 ET | [10-Q](/filings/0000950170-24-119249.md) | Quarterly report, period 2024-09-30 | 0000950170-24-119249 |
| 2024-10-31 | 07:40 ET | [8-K](/filings/0000950170-24-119245.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119245 |
| 2024-08-22 | 16:15 ET | [SC 13D/A](/filings/0001104659-24-091998.md) | Ownership report, active investor, amended | 0001104659-24-091998 |
| 2024-08-20 | 17:24 ET | [8-K](/filings/0001193125-24-203755.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-203755 |
| 2024-08-07 | 07:15 ET | [10-Q](/filings/0000950170-24-092275.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092275 |
| 2024-08-07 | 07:10 ET | [8-K](/filings/0000950170-24-092272.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092272 |
| 2024-07-08 | 16:22 ET | [8-K](/filings/0001193125-24-176312.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-176312 |
| 2024-06-20 | 17:01 ET | [8-K](/filings/0001193125-24-164550.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-164550 |
| 2024-05-02 | 07:15 ET | [10-Q](/filings/0000950170-24-051567.md) | Quarterly report, period 2024-03-31 | 0000950170-24-051567 |
| 2024-05-02 | 07:10 ET | [8-K](/filings/0000950170-24-051566.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051566 |

Page 1 of 3. [Older](/companies/kymr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:17 ET. No prices; not investment advice.